Radiofrequency Enhanced Cosmetic Composition Delivery
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of the original patent to develop novel systems and methods for enhanced delivery of cosmetic compositions to skin regions, promoting skin rejuvenation, hair growth, and acne treatment.
Background and Problem Solved
Current cosmetic treatments often rely on topical creams or invasive procedures, which may have limited efficacy or cause unwanted side effects. The original patent's technology, initially designed for treating occlusions in blood vessels, can be adapted to address these limitations in the cosmetic industry.
Detailed Description of the Inventive Concept
The inventive concept utilizes radiofrequency energy to enhance the delivery of cosmetic compositions, such as therapeutic agents, pharmaceutical compounds, or skin rejuvenation formulas, to specific skin regions. The system comprises a radiofrequency energy source and a composition delivery element, which can be configured to target various skin concerns, including acne, hair loss, and hyperpigmentation. The method involves directing the radiofrequency energy source to the skin region and providing the cosmetic composition, allowing for controlled and prolonged delivery.
Novelty and Inventive Step
The inventive concept introduces a new application of the original patent's technology, shifting from treating occlusions in blood vessels to enhancing cosmetic composition delivery in the skin. This adaptation constitutes a non-obvious and novel use of the core technology.
Alternative Embodiments and Variations
Alternative embodiments may include varying the type of radiofrequency energy, adjusting the composition delivery element's design, or incorporating additional features, such as temperature control or sensing mechanisms, to optimize the system's performance. Variations could also involve using different cosmetic compositions or targeting specific skin conditions, such as rosacea or psoriasis.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the cosmetic industry, with applications in skincare, hair care, and dermatology. The target market includes cosmetic companies, dermatology clinics, and medical spas, with potential for expansion into the consumer market.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M37/00 |
| A | A61 | A61B17/22 |
| A | A61 | A61N1/306 |
| A | A61 | A61N1/40 |
| A | A61 | A61N1/44 |
| A | A61 | A61B18/14 |
| A | A61 | A61B2017/22001 |
| A | A61 | A61B2017/22005 |
| A | A61 | A61B2017/22084 |
| A | A61 | A61B2018/0022 |
| A | A61 | A61K9/0009 |
| A | A61 | A61M25/104 |
| A | A61 | A61M2025/0057 |
| A | A61 | A61M2025/105 |
| A | A61 | A61M2037/0007 |
| A | A61 | A61N1/327 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technologies and energy-based therapeutic delivery systems, specifically involving radiofrequency energy for targeted composition delivery across biological tissues
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in energy-based medical interventions, familiar with radiofrequency technologies, tissue interaction principles, and cross-domain application of energy-assisted delivery techniques
Obviousness Rationale
A PHOSITA would recognize that the core radiofrequency energy delivery mechanism disclosed in the source patent represents a generalizable technique for enhancing composition penetration across biological tissues. The fundamental principles of using radiofrequency energy to modulate tissue permeability and facilitate targeted delivery are directly transferable between medical and cosmetic applications. The PTD demonstrates a predictable extension of the original patent's core technological concept by applying the same energy-based delivery mechanism to different tissue types and compositional goals.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,748 |
|---|---|
| Title | Method and device for enhanced composition delivery |
| Assignee(s) | ASAHI MEDICAL TECHNOLOGIES, INC. |